Business Context and Reporting Period
Immuron Limited, a foreign private issuer based in Australia, filed this Form 6-K for the month of October 2023. The filing serves to disseminate a public announcement made to the Australian Securities Exchange on October 30, 2023.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an informational notice regarding a corporate event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Guidance, Outlook, and Management Commentary
The primary content of this filing is an announcement that Immuron CEO Steven Lydeamore is scheduled to present at the AusBioInvest conference. The filing explicitly states that it is not deemed "filed" for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly set forth.
Key Facts for Investor Verification
- The filing is a Form 6-K reporting a single public notice regarding a CEO presentation at AusBioInvest.
- No financial results or operational metrics are included in this specific document.
- The registrant is Immuron Limited, with its principal executive office in Carlton South, Victoria, Australia.
- The report was signed by Phillip Hains, Company Secretary, on October 30, 2023.